International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7797216
Original Article
Prognostic Significance of Worst Pattern of Invasion in oral cavity Squamous Cell Carcinoma in relation to lymph node metastasis —A Retrospective Study from tertiary care centre
 ,
 ,
 ,
 ,
Published
April 4, 2023
Abstract
Introduction: Squamous cell carcinoma is the most common head and neck carcinoma, comprising 90% of cancers of the head and neck region1.Globally, oral cancer ranks sixth among all types of cancer. India has the largest number of oral cancer cases and one-third of the total burden of oral cancer globally. It is an important cause of morbidity and mortality worldwide. Oral cavity Squamous Cell Carcinoma(OSCC) commonly results from potentially malignant lesions or normal epithelium linings. Oral SCC spread typically occurs via lymphatic system. Conventional OSCC is aggressive, with a propensity for local invasion & early lymph node metastasis. Lymph node involvement is important prognostic factor in OSCC. So it’s important to access most influencing histological parameter in association with lymph node metastasis. This study was conducted to evaluate the role of histological parameters including Worst pattern of invasion (WPOI) and Depth of invasion (DOI) to determine the risk of LN metastasis in cases of OSCC. Objective: To evaluate the role of worst pattern of invasion to determine risk of lymph node metastasis in oral squamous cell carcinomas. Methodology: After receiving an approval of institutional ethical committee the study was conducted in histopathology section of pathology department. This was a retrospective study. All the cases of buccalmucosa and tongue SCC who underwent resection with cervical lymph node dissection in our institute from October 2021 to January 2023 were included. Cases where patient received preoperative radiotherapy or chemotherapy or where LN dissection was not performed or where slides were not available for review were excluded. Total 108 cases were evaluated and slides were stained by H & E and examined microscopically. Collected data is entered in Microsoft excel. Observation And Results: A total of 108 cases were studied, which included 94 males and 14 females (M:F = 6.7:1). 76 (70.37%) cases were of above 50 years of age and 32 (29.6%) cases were of below 50 years of age (average: 47.2 years). The most common site in our study was buccal mucosa (42 cases i.e. 38.8%). P value is 0.00(at 5% level of significance), so there is strong association between DOI of tumor with WPOI. p value is 0.0092(at 10% level of significance ), so there is strong association between lymph node metastasis and WPOI. In this study number of cases of moderately and poorly differentiated tumors is 48 out of which 24 (50%) cases were positive for LN metastasis and out of 60 well differentiated tumors 12 (20%) were positive for Lymph node metastasis with p value 0.02 at 5% level of significance. Other parameters such as tumor grade, tumor stage, lymphovascular emboli(LVE), perneural infiltration(PNI), Tumor thickness do not show any significant association with WPOI. Conclusion: The present study concluded that aggressive POI are significantly associated with number of lymph nodes metastasis and Depth of invasion and hence can be an independent histopathologic prognostic parameter in OSCC
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2584 Views
344 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved